BCL2 and Alzheimer disease: In Alzheimer’s disease (AD) cell model, DPSCs’ secretome reduced the amyloid beta (Aβ) peptide-mediated cell cytotoxicity and apoptosis by stimulating the endogenous survival factor Bcl-2 and decreasing the apoptotic regulator Bax (Ahmed Nel et al., 2016).